Clear Creek Bio doses first patient in phase 2 outpatient study of Brequinar to treat Covid-19

Clear Creek Bio doses first patient in phase 2 outpatient study of Brequinar to treat Covid-19. (Credit: Daniel Roberts from Pixabay)